Nanosonics Ltd represents innovation, quality, and a commitment to improving healthcare standards. Their corporate philosophy revolves around providing advanced infection prevention solutions to enhance patient safety and ensure superior medical device reprocessing. Nanosonics is known for developing and commercializing the Trophon® EPR, an environmentally friendly and efficient disinfection system for ultrasound probes. With a strong focus on research and development, Nanosonics strives to deliver cutting-edge technology that meets industry standards and continues to make a positive impact in the healthcare sector.

Nanosonics Ltd is primarily present in several countries and regions worldwide. The company has a global presence, with a strong focus on the healthcare sector. Nanosonics products and solutions are widely utilized in healthcare facilities across the United States, Canada, Europe, Asia Pacific countries, and Australia. As a leading global company, Nanosonics Ltd continues to expand its market reach and establish a strong presence in various regions to meet the growing demand for its innovative infection prevention technologies.

Nanosonics Ltd has achieved several significant milestones. One notable achievement is the development and commercialization of their pioneering Trophon EPR device. This innovative ultrasound probe disinfection system has revolutionized infection control in healthcare facilities worldwide. Nanosonics Ltd also expanded their global presence by establishing partnerships and securing regulatory approvals in key markets, further enhancing their market position. Additionally, the company has demonstrated consistent growth and financial success over the years, fostering investor confidence. Nanosonics Ltd continues to innovate and drive advancements in the field of infection prevention, cementing their position as a leader in the healthcare industry.

Nanosonics Ltd is an Australia-based medical technology company specializing in infection control solutions. Founded in 2001, Nanosonics has become a global leader in developing and commercializing innovative products for healthcare settings. The company's flagship product, Trophon, is a disinfection system for ultrasound probes, effectively preventing the spread of infections. Nanosonics' commitment to research and development has led to numerous awards, recognizing their pioneering technology and dedication to improving patient safety. With a strong focus on quality and customer satisfaction, Nanosonics continues to revolutionize the healthcare industry with their advanced infection prevention solutions.

The main competitors of Nanosonics Ltd in the market include companies such as Johnson & Johnson, General Electric Company, Diversey Inc., and Ecolab Inc. These companies compete with Nanosonics Ltd in the healthcare industry, specifically in the field of infection prevention and control. Nanosonics Ltd has established a strong position in the market with its innovative disinfection and decontamination technologies. Despite facing competition from these major players, Nanosonics Ltd continues to differentiate itself through its cutting-edge products and solutions, ensuring healthcare facilities can provide optimal patient care and safety.

Nanosonics Ltd is primarily active in the healthcare industry.

The business model of Nanosonics Ltd revolves around the development, manufacturing, and distribution of innovative infection prevention solutions for the healthcare industry. Nanosonics specializes in the creation of trophon® EPR, an ultrasound probe disinfection system that effectively eliminates harmful microorganisms, reducing the risk of healthcare-associated infections. By leveraging advanced nanotechnology, Nanosonics aims to provide healthcare professionals with safe, efficient, and cost-effective solutions to enhance patient safety. Through its commitment to delivering cutting-edge sterilization technologies, Nanosonics has established itself as a leading player in the global healthcare sector.

Az Nanosonics P/E mutatója 71,91.

Az Nanosonics KUV 5,49.

Az AlleAktien Minőségi Score Nanosonics esetében 4/10.

A Nanosonics forgalma 170,01 Mió. AUD.

A(z) Nanosonics nyereség 12,97 Mió. AUD.

Nanosonics Ltd is an innovative company specializing in the development and marketing of products in the field of ultrasound disinfection and sterilization. The company was founded in Australia in 2001 and has since become a global leader in this field. Nanosonics Ltd's business model is based on three pillars: research and development, production, and distribution. Research and development: Nanosonics Ltd conducts intensive research and development in collaboration with leading academic and medical institutions around the world. The goal is to develop new technologies and products to make the sterilization and disinfection process more efficient, safer, and environmentally friendly. The company annually invests a high percentage of its revenue in research and development. Production: Nanosonics Ltd manufactures its products in its own factories in Australia and Singapore at the highest technological level. Emphasis is placed on quality, reliability, and sustainability. The company utilizes modern manufacturing processes and maintains high standards for quality control and safety testing in the production process. Nanosonics Ltd places great importance on implementing green technologies in its production and operations. Distribution: Nanosonics Ltd distributes its products internationally in collaboration with partners, dealers, and distributors. The focus is on industrialized countries such as the USA, Europe, Australia, and Japan. The company employs an intensive marketing and distribution strategy to strengthen its presence in global markets. The focus is on close collaboration with customers to better understand their needs and requirements, thus being able to offer tailor-made solutions for their specific applications. Nanosonics Ltd's products: Currently, the company offers two products for ultrasound disinfection and sterilization. These are the Trophon EPR and Trophon2. Both products have been specifically developed for medical use to provide the highest level of safety around the patient. The Trophon EPR and Trophon2 offer a comprehensive solution for the complete cleaning and disinfection of ultrasound probes in medical practice. The products utilize Trophon technology to ensure effective, fast, and safe sterilization that can be reliably performed even under highly demanding conditions. In addition to the readiness and effectiveness of the products, Nanosonics Ltd focuses on environmentally friendly manufacturing. The products are designed to comply with strict environmental and safety standards and reduce CO2 emissions. Preserving the environment is always one of Nanosonics Ltd's central goals alongside safety. With Nanosonics Ltd's products, the medical world is always one step ahead in the fight against infections and sterilized equipment. The Trophon EPR and Trophon2 are examples of Nanosonics Ltd's innovative technologies that solve complex sanitary problems and elevate environmentally friendly technologies to a new level.

A(z) Nanosonics évente alkalommal oszt ki 0 AUD összegű osztalékot.

A Nanosonics esetében jelenleg nem lehet kiszámítani a osztalékot, vagy a vállalat nem fizet osztalékot.

A(z) Nanosonics ISIN kódja: AU000000NAN9.

A Nanosonics WKN-je A0MQVE.

Az Nanosonics tőzsdei rövidítése NAN.AX.

Az elmúlt 12 hónapban a(z) Nanosonics osztalékot fizetett összegben. Ez körülbelül osztalékhozamnak felel meg. A következő 12 hóban a(z) Nanosonics várhatóan 0 AUD összegű osztalékot fog fizetni.

A(z) Nanosonics jelenlegi osztalékhozama .

A(z) Nanosonics negyedévente fizet osztalékot. Az osztalékokat a következő hónapokban osztják ki: .

A Nanosonics az elmúlt 0 évben minden évben fizetett osztalékot.

A következő 12 hónapban 0 AUD összegű osztalékra számítanak. Ez 0 % osztalékhozamnak felel meg.

A(z) Nanosonics a(z) 'Egészség' szektorhoz van besorolva.

Az utolsó, Nanosonics által 2024. 12. 18.-án/én fizetett 0 AUD összegű osztalék megszerzéséhez a részvénynek az ex-nap előtti 2024. 12. 18.-nál kellett lennie a portfóliódban.

Az utolsó osztalék kifizetése 2024. 12. 18. időpontban történt.

2023 évben a Nanosonics 0 AUD összegű osztalékot fizetett ki.

Az Nanosonics osztalékait AUD fizeti ki.